baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

JP Morgan Put 60 CVS 18.10.2024/ DE000JK7N717 /

09/08/2024 12:09:22	Chg.-0.110	Bid22:00:40	Ask22:00:40	Underlying	Strike price	Expiration date	Option type
0.360EUR	-23.40%	- Bid Size: -	- Ask Size: -	CVS Health Corporati...	60.00 USD	18/10/2024	Put

TeleTrader 07/08 US opens higher as earnings pour in

TeleTrader 07/08 CVS reports Q2 revenue of $91.2B, up 2.6%

TeleTrader 06/08 Musk's X sues ad industry group for violating antitrust laws

GlobeNewswire 15/06 CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of CVS Stoc...

Newsfile Corp 10/06 Guest Invitation to Momentum AI Summit in July

GlobeNewswire 05/06 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corpo...

Newsfile Corp 28/05 Community Health and Resource Event in Miami: IBTU and Aetna CVS Health Unite for Health Equity

GlobeNewswire 28/05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corpo...

GlobeNewswire 28/05 The Institute for Value-Based Medicine® from The American Journal of Managed Care® hosts Advancing V...

GlobeNewswire 21/05 Moonstone Nutrition Launches New Investment Opportunity on StartEngine to Fuel Company Growth and Pr...

GlobeNewswire 20/05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corpo...

GlobeNewswire 15/05 ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages CVS Health Corporation Investors to Inquire About ...

GlobeNewswire 13/05 64% OF U.S. HOUSEHOLDS BUY SEASONAL ALLERGY MEDICATION; 72% OF BUYERS SAY BRAND NAME AND PRIVATE LAB...

GlobeNewswire 12/05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corp...

GlobeNewswire 11/05 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Inquire About Securi...

GlobeNewswire 02/05 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVS Health Corpo...

TeleTrader 01/05 US closes mixed after Powell's remarks

GlobeNewswire 01/05 INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Cor...

TeleTrader 01/05 CVS plunges 20% after disappointing earnings outlook

TeleTrader 01/05 CVS's Q1 revenue up by 3.7% to $88.4B

GlobeNewswire 18/04 The New York Academy of Medicine Announces New Board of Trustee Members

GlobeNewswire 17/04 Washington Spirit Celebrates First Ever Fan Goalkeeper Jerseys

GlobeNewswire 11/04 Sharecare teams up with Anthem Blue Cross and Blue Shield on Jump Shot for Health initiative to supp...

GlobeNewswire 09/04 ThoughtSpot Named Google Cloud Technology Partner of the Year for Data - Business Intelligence

GlobeNewswire 22/03 ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

JP Morgan Put 60 CVS 18.10.2024/ DE000JK7N717 /

If you wish to receive reply to your feedback, please provide your email address.